Washington, District of Columbia, United States
Contact Info
11K followers
500+ connections
About
Articles by Anshul
-
Rare Disease Day: Towards More Equitable Care
Rare Disease Day: Towards More Equitable Care
By Anshul Mangal
-
Unleashing the Power of Precision Medicine: Radioligand Therapy
Unleashing the Power of Precision Medicine: Radioligand Therapy
By Anshul Mangal
-
Scaling Hope: The Growth of Allogeneic Cell Therapy Sector
Scaling Hope: The Growth of Allogeneic Cell Therapy Sector
By Anshul Mangal
Activity
-
This week The City of Frederick: Department of Economic Development and Mayor Michael O'Connor toured the recent Precision For Medicine expansion…
This week The City of Frederick: Department of Economic Development and Mayor Michael O'Connor toured the recent Precision For Medicine expansion…
Liked by Anshul Mangal
-
"As we stand on the brink of a new era in solid tumor therapy, partnerships are needed to overcome manufacturing challenges." - @Emilie Pelletier…
"As we stand on the brink of a new era in solid tumor therapy, partnerships are needed to overcome manufacturing challenges." - @Emilie Pelletier…
Liked by Anshul Mangal
-
The #radiopharmaceutical sector is booming with significant #investments and deal-making activity. In the past two years alone 12 private…
The #radiopharmaceutical sector is booming with significant #investments and deal-making activity. In the past two years alone 12 private…
Shared by Anshul Mangal
Experience & Education
Licenses & Certifications
Volunteer Experience
-
Legal Volunteer
Heartland Alliance International
- 5 years
Civil Rights and Social Action
Heartland Alliance's National Immigration Justice Center provides legal services to low-income immigrants, refugees, and asylum seekers. Anshul led a team of five attorneys and successfully obtained asylum for a Pakistani refugee and helped obtain asylum for a Tibetan refugee.
-
Volunteer
Working in the Schools (WITS)
- 3 years
Children
WITS is an organization that promotes literacy among youth. Anshul provided one-on-one tutoring and mentoring to children.
-
Fundraising Volunteer
Cure SMA
- Present 9 years
Health
Cure SMA provides support to patients and families affected by spinal muscular atrophy and funds and directs research leading the way to a cure for SMA. Anshul, through Project Farma, has helped raise funds for the Cure SMA organization and brought awareness for SMA.
-
-
Chairman, Action for Equality Task Force
Alliance for Regenerative Medicine
- 3 years 6 months
Human Rights
Publications
-
New Tech on the Rise: The Future of Cell and Gene Therapies Is Here
PM360
Recent headlines suggest that the biotech industry as a whole is experiencing a downturn, yet in spite of this narrative the momentum for advanced therapies continues to persevere. Many companies in the cell and gene therapy space are dedicated to bringing these novel therapies to the patients who need them. Researchers are diligently creating new methods for cell and gene editing as well as therapeutic delivery to increase safety, accessibility, and affordability.
-
Leveraging education to close the advanced therapy talent gap
Drug Discovery World
The cell and gene therapy industry has experienced exponential growth in the last three years and as funding for the field continues to break records there are no signs of a slowdown. With 2,261 ongoing clinical trials in regenerative medicine, the FDA expects to approve1 between 10 and 20 new cell and gene therapies a year by 2025. Gene editing and CRISPR technologies are also quickly advancing with many companies heading to the clinic in the next few years. The need for solutions to the…
The cell and gene therapy industry has experienced exponential growth in the last three years and as funding for the field continues to break records there are no signs of a slowdown. With 2,261 ongoing clinical trials in regenerative medicine, the FDA expects to approve1 between 10 and 20 new cell and gene therapies a year by 2025. Gene editing and CRISPR technologies are also quickly advancing with many companies heading to the clinic in the next few years. The need for solutions to the industry’s biggest bottlenecks are growing daily.
-
Cell And Gene Therapies: Opportunities For Innovation
Cell & Gene
In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies are transforming the way diseases are treated but are also aiming to cure entirely new patient populations. New applications and indications are being researched daily with the hope to address an array of rare and chronic diseases that have long been thought incurable. As researchers and developers work to transform the way we treat diseases, cell and gene therapies will…
In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies are transforming the way diseases are treated but are also aiming to cure entirely new patient populations. New applications and indications are being researched daily with the hope to address an array of rare and chronic diseases that have long been thought incurable. As researchers and developers work to transform the way we treat diseases, cell and gene therapies will continue to be the center of innovation in the coming years.
Other authorsSee publication -
A shared opportunity: The future of cell and gene therapy
Benefits Pro
The commercialization of cell and gene therapies raises several complex conversations and questions for employers and payers. Without proper solutions and partnerships, employers and health insurers will be held responsible for extreme medical costs associated with gene therapy. Despite the many challenges of the last two years, the global cell and gene therapy (CGT) market continues to rapidly expand. The investment landscape for regenerative medicine has grown 16% in 3 years, hitting an…
The commercialization of cell and gene therapies raises several complex conversations and questions for employers and payers. Without proper solutions and partnerships, employers and health insurers will be held responsible for extreme medical costs associated with gene therapy. Despite the many challenges of the last two years, the global cell and gene therapy (CGT) market continues to rapidly expand. The investment landscape for regenerative medicine has grown 16% in 3 years, hitting an all-time high in 2021 of $23.1 billion raised. With more funding pouring in each year and over 2,261 ongoing global clinical trials in regenerative medicine, the market is expected to reach $34.31 billion in 2030. With this immense growth potential, the industry is reaching a tipping point heading towards commercialization. Cell and gene therapies provide hope for many patients suffering from rare diseases, creating great urgency to bring these treatments to market.
The commercialization of CGTs forces several complex economical conversations and questions, some concerns include manufacturing, labor challenges, payer coverage, adequate reimbursement, and cost-effectiveness. To find adequate solutions, we must first have a deep understanding of the process and factors driving the high-ticket price of these life-saving therapies.Other authorsSee publication
Languages
-
Hindi
Native or bilingual proficiency
More activity by Anshul
-
What a terrible feeling it must be as a clinician when you run out of treatment options for your patient. "'I (have) nothing left to give her' –…
What a terrible feeling it must be as a clinician when you run out of treatment options for your patient. "'I (have) nothing left to give her' –…
Liked by Anshul Mangal
-
Next week I’ll be joining the Cell & Gene Congressional Fly-In led by the Alliance for Regenerative Medicine in DC to show support for critical…
Next week I’ll be joining the Cell & Gene Congressional Fly-In led by the Alliance for Regenerative Medicine in DC to show support for critical…
Shared by Anshul Mangal
-
We are super excited to finish our series B with Morgan Stanley and Mucker. Huge thanks to Melissa Daniels, Will Hsu, Eric Olsen, and Harpreet…
We are super excited to finish our series B with Morgan Stanley and Mucker. Huge thanks to Melissa Daniels, Will Hsu, Eric Olsen, and Harpreet…
Liked by Anshul Mangal
-
In the latest development of the #BiosecureAct, which holds implications for #biotechs leveraging certain “companies of concern” outside the US…
In the latest development of the #BiosecureAct, which holds implications for #biotechs leveraging certain “companies of concern” outside the US…
Shared by Anshul Mangal
-
We are proud to announce our new Chief Medical Officer of Pain Management, Dr. Vipul Mangal. He will be seeing patients at our La Plata and Laurel…
We are proud to announce our new Chief Medical Officer of Pain Management, Dr. Vipul Mangal. He will be seeing patients at our La Plata and Laurel…
Liked by Anshul Mangal
-
This fall, 12-year-old Kendric Cromer will be the first in the nation to receive a groundbreaking #genetherapy aimed at curing his #sicklecell…
This fall, 12-year-old Kendric Cromer will be the first in the nation to receive a groundbreaking #genetherapy aimed at curing his #sicklecell…
Shared by Anshul Mangal
-
Reflecting on the groundbreaking advancements in #CARTcelltherapy, Medicine Maker revisits a powerful interview with Carl June, the pioneer behind…
Reflecting on the groundbreaking advancements in #CARTcelltherapy, Medicine Maker revisits a powerful interview with Carl June, the pioneer behind…
Shared by Anshul Mangal
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More